Neonatal Abstinence Syndrome after Methadone or Buprenorphine Exposure
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Methadone, a full mu-opioid agonist, is the recommended treatment for opioid dependence during pregnancy. However, prenatal exposure to methadone is associated with a neonatal abstinence syndrome (NAS) characterized by central nervous system hyperirritability and autonomic nervous system dysfunction, which often requires medication and extended hospitalization. Buprenorphine, a partial mu-opioid agonist, is an alternative treatment for opioid dependence but has not been extensively studied in pregnancy. METHODS: We conducted a double-blind, double-dummy, flexible-dosing, randomized, controlled study in which buprenorphine and methadone were compared for use in the comprehensive care of 175 pregnant women with opioid dependency at eight international sites. Primary outcomes were the number of neonates requiring treatment for NAS, the peak NAS score, the total amount of morphine needed to treat NAS, the length of the hospital stay for neonates, and neonatal head circumference. RESULTS: Treatment was discontinued by 16 of the 89 women in the methadone group (18%) and 28 of the 86 women in the buprenorphine group (33%). A comparison of the 131 neonates whose mothers were followed to the end of pregnancy according to treatment group (with 58 exposed to buprenorphine and 73 exposed to methadone) showed that the former group required significantly less morphine (mean dose, 1.1 mg vs. 10.4 mg; P<0.0091), had a significantly shorter hospital stay (10.0 days vs. 17.5 days, P<0.0091), and had a significantly shorter duration of treatment for the neonatal abstinence syndrome (4.1 days vs. 9.9 days, P<0.003125) (P values calculated in accordance with prespecified thresholds for significance). There were no significant differences between groups in other primary or secondary outcomes or in the rates of maternal or neonatal adverse events. CONCLUSIONS: These results are consistent with the use of buprenorphine as an acceptable treatment for opioid dependence in pregnant women. (Funded by the National Institute on Drug Abuse; ClinicalTrials.gov number, NCT00271219.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“the length, but not intensity, of neonatal abstinence syndrome and the neonates’ need for morphine relief was lower in women taking buprenorphine compared to methadone”
From Maintenance Medication for Opiate Addiction: The Foundation of Recovery (2012) · cites this paper as [134]
The cited source says what the claim attributes to it.
In the citing paper
“there was lower retention in the buprenorphine treated group.”
From Maintenance Medication for Opiate Addiction: The Foundation of Recovery (2012) · cites this paper as [134]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Intraclass correlations: Uses in assessing rater reliability.
Shrout, P. E., & Fleiss, J. L. (1979) · Psychological Bulletin · doi:10.1037/0033-2909.86.2.420 · Cited by 24,532
Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence
Mattick, R. P., Breen, C., Kimber, J., & Davoli, M. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002207.pub4 · Cited by 2,274
Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence
Mattick, R. P., Breen, C., Kimber, J., & Davoli, M. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002209.pub2 · Cited by 1,654
Jasinski, D. R. (1978) · Archives of General Psychiatry · doi:10.1001/archpsyc.1978.01770280111012 · Cited by 782 · cited 3×
“Eye, ear, nose, or throat problems 12 (14) 15 (17) 1 (1) 1 (2)”
A Comparison of Levomethadyl Acetate, Buprenorphine, and Methadone for Opioid Dependence
Johnson, R. E., Chutuape, M. A., Strain, E. C., Walsh, S. L., Stitzer, M. L., & Bigelow, G. E. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011023431802 · Cited by 623
Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence
Mattick, R. P., Kimber, J., Breen, C., & Davoli, M. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002207.pub3 · Cited by 501
A Controlled Trial Comparing Buprenorphine and Methadone Maintenance in Opioid Dependence
Ling, W. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830050035005 · Cited by 366 · cited 4×
“Obstetrical problems 29 (33) 23 (27) 3 (4) 4 (7)”
InfluentialBuprenorphine suppresses heroin use by heroin addicts
Mello, N. K., & Mendelson, J. H. (1980) · Science · doi:10.1126/science.7352279 · Cited by 298
Jones, H. E., Johnson, R. E., Jasinski, D. R., O’Grady, K. E., Chisholm, C. A., Choo, R. E., Crocetti, M., Dudas, R., Harrow, C., Huestis, M. A., et al. (2005) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2004.11.013 · Cited by 295
Self-citationOPIOID DEPENDENCE DURING PREGNANCY
Kaltenbach, K., Berghella, V., & Finnegan, L. (1998) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/s0889-8545(05)70362-4 · Cited by 287
Self-citation
Research works printed but not linked: 4
- 10.1111/j.1360-0443.1997.tb02877.x · doi:10.1111/j.1360-0443.1997.tb02877.x · Paper page
- Mattick RP, 2009, Cochrane Database Syst Rev, 3, CD002209
- Finnegan LP, Kaltenbach K. Neonatal abstinence syndrome. In Hoekelman RA, Friedman SB, Nelson NM, et al., eds. Primary pediatric care. 2nd ed. St. Louis: Mosby, 1992:1367-78.
- Mattick RP, 2008, Cochrane Database Syst Rev, 2, CD002207
Cited by
Items 101–200 of 1,000
Neonatal neurobehavior effects following buprenorphine versus methadone exposure
Coyle, M. G., Salisbury, A. L., Lester, B. M., Jones, H. E., Lin, H., Graf‐Rohrmeister, K., & Fischer, G. (2012) · Addiction · doi:10.1111/j.1360-0443.2012.04040.x · Cited by 92
Self-citationChen, S., Chen, H., Chiang, Y., Yuan, Z. F., Kuo, C.-C., Lai, M.-D., Hung, T., & Ho, I.-K. (2015) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s70585 · Cited by 94
Patient-centered Care to Address Barriers for Pregnant Women with Opioid Dependence
Sutter, M. B., Gopman, S., & Leeman, L. M. (2017) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2016.11.004 · Cited by 94
Neonatal abstinence syndrome: Historical perspective, current focus, future directions
Jones, H. E., & Fielder, A. L. (2015) · Preventive Medicine · doi:10.1016/j.ypmed.2015.07.017 · Cited by 94
Self-citationJones, H. E., Fischer, G., Heil, S. H., Kaltenbach, K. A., Martin, P., Coyle, M. G., Selby, P. L., Stine, S. M., O’Grady, K. E., & Arria, A. M. (2012) · Addiction · doi:10.1111/j.1360-0443.2012.04036.x · Cited by 92
Self-citationBackes, C. H., Backes, C. R., Gardner, D., Nankervis, C. A., Giannone, P. J., & Cordero, L. (2012) · Journal of Perinatology · doi:10.1038/jp.2011.114 · Cited by 89
Debelak, K., Morrone, W. R., O’Grady, K. E., & Jones, H. E. (2013) · American Journal on Addictions · doi:10.1111/j.1521-0391.2012.12005.x · Cited by 90
Self-citationPrenatal and Postpartum Care of Women with Substance Use Disorders
Gopman, S. (2014) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2014.02.004 · Cited by 88
Neonatal outcomes and their relationship to maternal buprenorphine dose during pregnancy
Jones, H. E., Dengler, E., Garrison, A., O’Grady, K. E., Seashore, C. J., Horton, E., Andringa, K., Jansson, L. M., & Thorp, J. M. (2013) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2013.11.006 · Cited by 89
Self-citationOpioid Use Disorder in Women and the Implications for Treatment
Barbosa‐Leiker, C., Campbell, A. N. C., McHugh, R. K., Guille, C., & Greenfield, S. F. (2020) · Psychiatric Research and Clinical Practice · doi:10.1176/appi.prcp.20190051 · Cited by 87
Visual outcome in infants born to drug-misusing mothers prescribed methadone in pregnancy
McGlone, L., Hamilton, R., McCulloch, D. L., MacKinnon, J. R., Bradnam, M. S., & Mactier, H. (2013) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2013-303967 · Cited by 87
Opioids in Breast Milk: Pharmacokinetic Principles and Clinical Implications
Ito, S. (2018) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.1113 · Cited by 87
Update on pharmacotherapy for treatment of opioid use disorder
Ayanga, D., Shorter, D., & Kosten, T. R. (2016) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2016.1244529 · Cited by 79
Perioperative Management of Buprenorphine: Solving the Conundrum
Quaye, A., & Zhang, Y. (2018) · Pain Medicine · doi:10.1093/pm/pny217 · Cited by 86
Corsi, D. J., Hsu, H., Fell, D. B., Wen, S. W., & WALKER, M. C. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.8256 · Cited by 85
Neonatal abstinence syndrome: Pharmacologic strategies for the mother and infant
Kraft, W. K., Stover, M. W., & Davis, J. M. (2016) · Seminars in Perinatology · doi:10.1053/j.semperi.2015.12.007 · Cited by 85
Pomar, E. M. G., & Finnegan, L. P. (2018) · Frontiers in Pediatrics · doi:10.3389/fped.2018.00033 · Cited by 84
Methadone, Buprenorphine, and Naltrexone for the Treatment of Opioid Use Disorder in Pregnant Women
Tran, T. H., Griffin, B. L., Stone, R. H., Vest, K. M., & Todd, T. J. (2017) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1958 · Cited by 73
Neonatal Opioid Withdrawal Syndrome
Sutter, M. B., Leeman, L. M., & Hsi, A. (2014) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2014.02.010 · Cited by 81
Treatment of opioid use disorder in primary care
Buresh, M., Stern, R. S., & Rastegar, D. A. (2021) · BMJ · doi:10.1136/bmj.n784 · Cited by 80
Executive function in preschool children prenatally exposed to methadone or buprenorphine
Konijnenberg, C., & Melinder, A. M. D. (2014) · Child Neuropsychology · doi:10.1080/09297049.2014.967201 · Cited by 80
Tobón, A. L., Habecker, E. L., & Forray, A. (2019) · Current Psychiatry Reports · doi:10.1007/s11920-019-1110-4 · Cited by 80
Women, opioid use and addiction
Goetz, T. G., Becker, J. B., & Mazure, C. M. (2021) · The FASEB Journal · doi:10.1096/fj.202002125r · Cited by 78
Methadone and perinatal outcomes: a prospective cohort study
Cleary, B., Eogan, M., O'Connell, M. P., Fahey, T. P., Gallagher, P., Clarke, T., White, M. J., McDermott, C., O’Sullivan, A., Carmody, D., et al. (2012) · Addiction · doi:10.1111/j.1360-0443.2012.03844.x · Cited by 78
Opioid Use Disorder: Medical Treatment Options.
Coffa, D. A., & Snyder, H. R. (2019) · PubMed · Cited by 77
Substance use in pregnancy: The medical challenge
Louw, K.-A. (2018) · Obstetric Medicine · doi:10.1177/1753495x17750299 · Cited by 76
Drug Use During Pregnancy Policies in the United States From 1970 to 2016
Thomas, S., Treffers, R. D., Berglas, N. F., Drabble, L. A., & Roberts, S. C. M. (2018) · Contemporary Drug Problems · doi:10.1177/0091450918790790 · Cited by 77
Women and Addiction: An Update
Ait‐Daoud, N., Blevins, D., Khanna, S., Sharma, S., Holstege, C. P., & Amin, P. A. (2019) · Medical Clinics of North America · doi:10.1016/j.mcna.2019.03.002 · Cited by 76
O'Connor, A. B., Collett, A., Alto, W. A., & O'Brien, L. M. (2013) · Journal of Midwifery & Women's Health · doi:10.1111/jmwh.12009 · Cited by 73
Guidelines for the Management of Pregnant Women With Substance Use Disorders
McLafferty, L. P., Becker, M. A., Dresner, N., Meltzer-Brody, S. E., Gopalan, P. R., Glance, J. B., Victor, G. S., Mittal, L. P., Marshalek, P. J., Lander, L. R., et al. (2015) · Psychosomatics · doi:10.1016/j.psym.2015.12.001 · Cited by 75
Goodman, D., Milliken, C. U., Theiler, R. N., Nordstrom, B. R., & Akerman, S. C. (2015) · Journal of Dual Diagnosis · doi:10.1080/15504263.2015.1104484 · Cited by 74
Jones, H. E., Chisolm, M. S., Jansson, L. M., & Terplan, M. (2012) · Addiction · doi:10.1111/j.1360-0443.2012.03811.x · Cited by 73
Self-citationLund, I. O., Fischer, G., Welle-Strand, G. K., O’Grady, K. E., Debelak, K., Morrone, W. R., & Jones, H. E. (2013) · Substance Abuse Research and Treatment · doi:10.4137/sart.s10955 · Cited by 74
Self-citationBastian, J. R., Chen, H., Zhang, H., Rothenberger, S. D., Tarter, R. E., English, D., Venkataramanan, R., & Caritis, S. N. (2016) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2016.09.095 · Cited by 73
Davidson, L., & Boland, M. R. (2020) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1007/s10928-020-09685-1 · Cited by 73
Laser Acupuncture for Neonatal Abstinence Syndrome: A Randomized Controlled Trial
Raith, W., Schmölzer, G. M., Resch, B., Reiterer, F., Avian, A., Köestenberger, M., & Urlesberger, B. (2015) · PEDIATRICS · doi:10.1542/peds.2015-0676 · Cited by 72
Comparison between buprenorphine provider availability and opioid deaths among US counties
Jones, C. W., Christman, Z., Smith, C. M., Safferman, M. R., Salzman, M., Baston, K., & Haroz, R. (2018) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2018.07.008 · Cited by 73
Maintenance agonist treatments for opiate-dependent pregnant women
Minozzi, S., Amato, L., Jahanfar, S., Bellisario, C., Ferri, M., & Davoli, M. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006318.pub4 · Cited by 72
Hand, D. J., Short, V. L., & Abatemarco, D. J. (2017) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2017.01.011 · Cited by 71
Pharmacotherapy for Substance Use Disorders
Klein, J. W. (2016) · Medical Clinics of North America · doi:10.1016/j.mcna.2016.03.011 · Cited by 71
Grossman, M., & Berkwitt, A. K. (2019) · Seminars in Perinatology · doi:10.1053/j.semperi.2019.01.007 · Cited by 71
Licit and illicit drug use during pregnancy: maternal, neonatal and early childhood consequences.
Finnegan, L. P. (2013) · Cited by 72
Neonatal Abstinence Syndrome: Update on Diagnostic and Therapeutic Strategies
Raffaeli, G., Cavallaro, G., Allegaert, K., Wildschut, E. D., Fumagalli, M., Agosti, M. A., Tibboel, D., & Mosca, F. (2017) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1954 · Cited by 69
Endogenous opiates and behavior: 2011
Bodnar, R. J. (2012) · Peptides · doi:10.1016/j.peptides.2012.09.027 · Cited by 69
Black, K. I., & Day, C. (2016) · Substance Abuse Research and Treatment · doi:10.4137/sart.s34555 · Cited by 69
Opioid dependence and pregnancy: minimizing stress on the fetal brain
McCarthy, J. J., Leamon, M. H., Finnegan, L. P., & Fassbender, C. (2016) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2016.10.003 · Cited by 68
Chisolm, M. S., Fitzsimons, H., Leoutsakos, J., Acquavita, S. P., Heil, S. H., Wilson-Murphy, M., Tuten, M., Kaltenbach, K. A., Martin, P., Winklbaur, B., et al. (2013) · Nicotine & Tobacco Research · doi:10.1093/ntr/nts274 · Cited by 67
Self-citationA Cohort Comparison of Buprenorphine versus Methadone Treatment for Neonatal Abstinence Syndrome
Hall, E. S., Isemann, B. T., Wexelblatt, S. L., Meinzen‐Derr, J. K., Wiles, J. R., Harvey, S., & Akinbi, H. T. (2015) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2015.11.039 · Cited by 67
Guille, C., Simpson, A. N., Douglas, E., Boyars, L., Cristaldi, K. K., McElligott, J. T., Johnson, D., & Brady, K. T. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.20177 · Cited by 67
Variations in opioid receptor genes in neonatal abstinence syndrome
Wachman, E. M., Hayes, M. J., Sherva, R., Brown, M. S., Davis, J. M., Farrer, L. A., & Nielsen, D. A. (2015) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2015.07.001 · Cited by 66
Clinical Correlates of Prescription Opioid Analgesic Use in Pregnancy
Smith, M. V., Costello, D. M., & Yonkers, K. A. (2014) · Maternal and Child Health Journal · doi:10.1007/s10995-014-1536-6 · Cited by 66
Witt, C. E., Rudd, K. E., Bhatraju, P. K., Rivara, F. P., Hawes, S. E., & Weiss, N. S. (2017) · Journal of Perinatology · doi:10.1038/jp.2017.106 · Cited by 66
Buprenorphine-naloxone use in pregnancy: a systematic review and metaanalysis
Link, H. M., Jones, H. E., Miller, L. A., Kaltenbach, K. A., & Seligman, N. S. (2020) · American Journal of Obstetrics & Gynecology MFM · doi:10.1016/j.ajogmf.2020.100179 · Cited by 66
Self-citationBuprenorphine Pharmacodynamics and Pharmacokinetics
WALSH, S. L., & Middleton, L. S. (2013) · Springer eBooks · doi:10.1007/978-1-4614-6974-2_12 · Cited by 65
Universal Maternal Drug Testing in a High-Prevalence Region of Prescription Opiate Abuse
Wexelblatt, S. L., Ward, L. P., Torok, K., Tisdale, E., Meinzen‐Derr, J. K., & Greenberg, J. M. (2014) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2014.10.004 · Cited by 65
Meinhofer, A., Hinde, J. M., & Ali, M. M. (2019) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2019.12.005 · Cited by 65
Eschenroeder, A. C., Vestal-Laborde, A. A., Sanchez, E. S., Robinson, S. E., & Sato‐Bigbee, C. (2011) · Glia · doi:10.1002/glia.21253 · Cited by 64
Konijnenberg, C., Sarfi, M., & Melinder, A. (2016) · Early Human Development · doi:10.1016/j.earlhumdev.2016.08.013 · Cited by 63
Peripartum pain management in opioid dependent women
Höflich, A. S., Langer, M., Jagsch, R., Bäwert, A., Winklbaur, B., Fischer, G., & Unger, A. (2011) · European Journal of Pain · doi:10.1016/j.ejpain.2011.08.008 · Cited by 61
Self-citationThe Effect of Methadone Dose Regimen on Neonatal Abstinence Syndrome
McCarthy, J. J., Leamon, M. H., Willits, N. H., & Salo, R. E. (2015) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000099 · Cited by 61
Short, V. L., Gannon, M. A., & Abatemarco, D. J. (2016) · Breastfeeding Medicine · doi:10.1089/bfm.2016.0084 · Cited by 64
“I didn’t want to be on Suboxone at first…” – Ambivalence in Perinatal Substance Use Treatment
Ostrach, B. M. M., & Leiner, C. (2018) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000491 · Cited by 61
Landau, R. (2019) · International Journal of Obstetric Anesthesia · doi:10.1016/j.ijoa.2019.01.011 · Cited by 61
Benningfield, M. M., Dietrich, M. S., Jones, H. E., Kaltenbach, K., Heil, S. H., Stine, S. M., Coyle, M. G., Arria, A. M., O'Grady, K. E., Fischer, G., et al. (2012) · Addiction · doi:10.1111/j.1360-0443.2012.04041.x · Cited by 60
“Opioid dependence occurring during pregnancy is a significant public health challenge resulting in potential risks to mother and fetus and enormous healthcare costs [1,2].”
BackgroundInfluentialSelf-citationPharmacologic Management of the Opioid Neonatal Abstinence Syndrome
Kraft, W. K., & van den Anker, J. N. (2012) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2012.07.006 · Cited by 60
Screening for Substance Abuse in Women's Health: A Public Health Imperative
Goodman, D., & Wolff, K. B. (2013) · Journal of Midwifery & Women s Health · doi:10.1111/jmwh.12035 · Cited by 60
Kelty, E. A., & Hulse, G. K. (2017) · Drugs · doi:10.1007/s40265-017-0763-8 · Cited by 60
Lo‐Ciganic, W., Donohue, J. M., Kim, J. Y., Krans, E. E., Jones, B. L., Kelley, D., James, A. E., & Jarlenski, M. P. (2019) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.4647 · Cited by 55
Pharmacokinetics of Oral Methadone in the Treatment of Neonatal Abstinence Syndrome: A Pilot Study
Wiles, J. R., Isemann, B. T., Mizuno, T., Tabangin, M. E., Ward, L. P., Akinbi, H. T., & Vinks, A. A. T. M. M. (2015) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2015.08.032 · Cited by 59
Prenatal exposure to methadone or buprenorphine impairs cognitive performance in young adult rats
Kongstorp, M., Bogen, I. L., Stiris, T., & Andersen, J. M. (2020) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2020.108008 · Cited by 59
Buprenorphine Compared with Methadone in Pregnancy: A Systematic Review and Meta-Analysis
Kinsella, M., Halliday, L., Shaw, M., Capel, Y., Nelson, S. M., & Kearns, R. J. (2022) · Substance Use & Misuse · doi:10.1080/10826084.2022.2083174 · Cited by 59
Neonatal Opioid Withdrawal Syndrome (NOWS): A Transgenerational Echo of the Opioid Crisis
Weller, A. E., Crist, R. C., Reiner, B. C., Doyle, G. A. R., & Berrettini, W. H. (2020) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a039669 · Cited by 58
Clinical Management of Opioid Withdrawal.
Torres‐Lockhart, K. E., Lu, T. Y., Weimer, M. B., Stein, M. R., & Cunningham, C. O. (2022) · Addiction · doi:10.1111/add.15818 · Cited by 57
Impact of treatment approach on maternal and neonatal outcome in pregnant opioid‐maintained women
Metz, V. E., Jagsch, R., Ebner, N., Würzl, J., Pribasnig, A., Aschauer, C., & Fischer, G. (2011) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.1224 · Cited by 57
Self-citationDevelopmental Consequences of Prenatal Substance Use in Children and Adolescents
Guille, C., & Aujla, R. (2019) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2018.0177 · Cited by 57
Opioids affect the fetal brain: reframing the detoxification debate
Caritis, S. N., & Panigrahy, A. (2019) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2019.07.022 · Cited by 56
Allocco, E. R., Melker, M., Rojas-Miguez, F., Bradley, C., Hahn, K. A., & Wachman, E. M. (2016) · Advances in Neonatal Care · doi:10.1097/anc.0000000000000320 · Cited by 56
Daley, D. C., Smith, E., Balogh, D., & Toscaloni, J. (2018) · Commonwealth · doi:10.15367/com.v20i2-3.189 · Cited by 45
Breastfeeding and Substance Abuse
D'Apolito, K. (2013) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0b013e31827e6b71 · Cited by 55
Coyle, M. G., Brogly, S. B., Ahmed, M. S., Patrick, S. W., & Jones, H. E. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0045-0 · Cited by 55
Self-citationClinical Research Enrolling Pregnant Women: A Workshop Summary
Foulkes, M. A., Grady, C., Spong, C. Y., Bates, A., & Clayton, J. A. (2011) · Journal of Women s Health · doi:10.1089/jwh.2011.3118 · Cited by 54
Current Management of Neonatal Abstinence Syndrome Secondary to Intrauterine Opioid Exposure
Wiles, J. R., Isemann, B. T., Ward, L. P., Vinks, A. A. T. M. M., & Akinbi, H. T. (2014) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2014.05.010 · Cited by 54
Pomar, E. M. G., Finnegan, L. P., Devlin, L. A., Bada, H. S., Concina, V. A., Ibonia, K. T., & Westgate, P. M. (2017) · BMJ Open · doi:10.1136/bmjopen-2017-016176 · Cited by 54
Fetal assessment before and after dosing with buprenorphine or methadone
Salisbury, A. L., Coyle, M. G., O’Grady, K. E., Heil, S. H., Martin, P., Stine, S. M., Kaltenbach, K. A., Weninger, M., & Jones, H. E. (2012) · Addiction · doi:10.1111/j.1360-0443.2012.04037.x · Cited by 54
Self-citationUpdate on the clinical use of buprenorphine: in opioid-related disorders.
Ducharme, S., Fraser, R., & Gill, K. (2012) · Canadian Family Physician · Cited by 53
Jones, H. E., Jansson, L. M., O’Grady, K. E., & Kaltenbach, K. A. (2013) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2013.05.003 · Cited by 53
Self-citationClinical, Ethical, and Legal Considerations in Pregnant Women With Opioid Abuse
Kremer, M. E., & Arora, K. S. (2015) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000000991 · Cited by 53
The opioid epidemic and neonatal abstinence syndrome in the USA: a review of the continuum of care
Pryor, J. R., Maalouf, F. I., Krans, E. E., Schumacher, R. E., Cooper, W. O., & Patrick, S. W. (2017) · Archives of Disease in Childhood Fetal & Neonatal · doi:10.1136/archdischild-2015-310045 · Cited by 52
Breastfeeding Considerations for Mothers of Infants with Neonatal Abstinence Syndrome
Holmes, A. P., Schmidlin, H. N., & Kurzum, E. N. (2017) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1944 · Cited by 52
Prenatal Treatment and Outcomes of Women With Opioid Use Disorder
Brogly, S. B., Saia, K., Werler, M. M., Regan, E., & Hernández–Díaz, S. (2018) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000002881 · Cited by 52
Jones, H. E., & Kaltenbach, K. A. (2012) · JAMA · doi:10.1001/jama.2012.8595 · Cited by 52
Self-citationBuprenorphine/Naloxone for opioid dependence: clinical practice guideline.
Handford, C. D., Kahan, M., Srivastava, A., Cirone, S., & Palda, V. A. (2011) · Cited by 51
Growth and developmental outcome of infants with in-utero exposure to methadone vs buprenorphine
Bier, J. B., Finger, A., Bier, B., Johnson, T. A., & Coyle, M. G. (2015) · Journal of Perinatology · doi:10.1038/jp.2015.22 · Cited by 51
Self-citationA Qualitative Study of Family Experience With Hospitalization for Neonatal Abstinence Syndrome
Atwood, E. C., Sollender, G. E., Hsu, E., Arsnow, C., Flanagan, V., Celenza, J., Whalen, B. L., & Holmes, A. V. (2016) · Hospital Pediatrics · doi:10.1542/hpeds.2016-0024 · Cited by 52
Methadone Treatment of Opiate Addiction: A Systematic Review of Comparative Studies.
Ali, S., Tahir, B., Jabeen, S., & Malik, M. (2017) · PubMed · Cited by 51
Buprenorphine and Methadone for Opioid Addiction During Pregnancy
Mozurkewich, E., & Rayburn, W. F. (2014) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2014.02.005 · Cited by 51
Neonatal Abstinence Syndrome: Essentials for the Practitioner
Siu, A., & Robinson, C. A. (2014) · The Journal of Pediatric Pharmacology and Therapeutics · doi:10.5863/1551-6776-19.3.147 · Cited by 51
Jumah, N. A., Edwards, C., Balfour-Boehm, J., Loewen, K., Dooley, J., Gerber-Finn, L., & Kelly, L. (2016) · BMJ Open · doi:10.1136/bmjopen-2016-011774 · Cited by 50
Opioid Use Disorder and Perinatal Outcomes
Piske, M., Homayra, F., Min, J. E., Zhou, H., Marchand, C., Mead, A., Ng, J., Woolner, M., & Nosyk, B. (2021) · PEDIATRICS · doi:10.1542/peds.2021-050279 · Cited by 50
The Role of Pharmacotherapy in the Treatment of Adolescent Substance Use Disorders
Hammond, C. J. (2016) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2016.05.004 · Cited by 38
Metadata
- Authors
- Jones, H. E., Kaltenbach, K., Heil, S. H., Stine, S. M., Coyle, M. G., Arria, A. M., O'Grady, K. E., Selby, P., Martin, P. R., & Fischer, G.
- Affiliations
- Johns Hopkins University (US)
- Thomas Jefferson University (US)
- University of Vermont (US)
- Wayne State University (US)
- Brown University (US)
- University of Maryland, College Park (US)
- University of Toronto (CA)
- Vanderbilt University (US)
- Medical University of Vienna (AT)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2010-12-09
- Volume
- 363
- Issue
- 24
- Pages
- 2320-2331
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- PMC
- PMC3073631
- OpenAlex
- W2025988777
- Cited by
- 986
- References
- 41
- Citations by year
- 2026: 33 · 2025: 38 · 2024: 44 · 2023: 56 · 2022: 45 · 2021: 59 · 2020: 67 · 2019: 97 · 2018: 51 · 2017: 139 · 2016: 72 · 2015: 58 · 2014: 63 · 2013: 56 · 2012: 78
- FWCI
- 46.34
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute on Drug Abuse (R01 DA15832, R01DA015778, R01DA 017513, R01DA015764, R01DA015832, R01DA015741, R01DA015738, R01DA018410, R01DA018417)
- National Center for Research Resources (M01-RR-109, M01RR000095, M01-RR-00095)
- Topics
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Prenatal Substance Exposure Effects
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
- Keywords
- neonatal abstinence syndrome, methadone, buprenorphine, opioid dependence in pregnancy, prenatal opioid exposure, mu-opioid receptor agonists, neonatal hospital stay, neonatal head circumference
- MeSH terms
- Adult, Buprenorphine, Double-Blind Method, Female, Head, Humans, Infant, Newborn, Length of Stay, Methadone, Morphine, Opioid-Related Disorders, Narcotics, Neonatal Abstinence Syndrome, Pregnancy, Pregnancy Complications, Logistic Models, History, Ancient
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.